Investor Relations
News ReleasesRSS
- Oct 17, 2018 F. Hoffmann-La Roche Announces Third Quarter Sales 2018
- Oct 15, 2018 Chugai Presents Results from Phase III Study of Satralizumab in NMOSD at ECTRIMS 2018
- Oct 15, 2018 Chugai Expresses its Support for the “Japan Climate Action Summit Declaration”
- Oct 12, 2018 Filing of Lawsuit on Patent Infringement Concerning Herceptin® Injection, and a Petition for Provisional Disposition Order (2)
- Oct 12, 2018 Filing of Lawsuit on Patent Infringement Concerning Herceptin® Injection, and a Petition for Provisional Disposition Order (1)
What's NewRSS
- Oct 04, 2018 Events & Presentations has been updated with the Date of the Financial Results
- Aug 31, 2018 Summary of the Chugai CEO Meeting
- Aug 03, 2018 Established ESG information site “ESG at Chugai”
- Jul 30, 2018 Webcast of Investor Conference on FY2018 2Q Financial Results
- Jul 27, 2018 Posted Corporate Governance Reports
